The more significant part of the total populace has no admittance to essential well-being administrations. About a portion of the 400,000 deaths a year attributed to incorrect diagnoses are viewed as preventable. Curai, a three-year-old startup, is using AI to improve the above condition. Curai's endeavors to bring down the obstruction to passage for medicinal services for billions of individuals focus on applying GPU-powered AI to interface patients, suppliers, and health coaches through a chat-based application. In the background, the application is intended to successfully interface the healthcare dots' entirety, from understanding side effects to making analyses to deciding medicines.

As a child, Neal Khosla became engrossed by the Oakland Athletics baseball team's "Moneyball" approach of using data analytics to uncover the value and potential of the sport's players. A few years ago, the young engineer began pursuing similar techniques to improve medical decision-making. It wasn't long after Khosla met Xavier Amatriain, who was looking to apply his engineering skills to a higher mission, that the pair founded Curai. The three-year-old startup, based in Palo Alto, Calif., is using AI to improve the entire process of providing healthcare. The scope of their challenge -- transforming how medical care is accessed and delivered -- is daunting.